New insights on the role of T cells in the pathogenesis of celiac disease

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 2, 2012, Pages 171-179

  Cianci, R ^a   Pagliari, D ^a   Landolfi, R ^a   Frosali, S ^a   Colagiovanni, A ^a   Cammarota, G ^a   Pandolfi, Franco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Celiac disease; Cytokines; Immunological niche; T lymphocytes; Th17; Treg

Indexed keywords

B7 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; GLIADIN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 27; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL INTERACTION; CELL KILLING; CYTOKINE PRODUCTION; CYTOTOXICITY; DUODENUM; DUODENUM MUCOSA; HUMAN; INFLAMMATION; INTESTINE VILLUS ATROPHY; MICROENVIRONMENT; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; T CELL LYMPHOMA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TISSUE INJURY;

CELIAC DISEASE; HUMANS; LYMPHOMA, T-CELL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84865026005     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105:910-22. (Pubitemid 23249504)
2. Frezza D, Giambra V, Cianci R, et al. Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol 2004; 39:1083-7. (Pubitemid 39536397)
3. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009; 9:858-70.
4. Ebert EC. Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes. Immunology 2009; 127:206-15.
5. Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 2007; 117:41-9. (Pubitemid 46048448)
6. Harris KM, Fasano A, Mann DL. Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease. Clin Immunol 2010; 135:430-9.
7. Qiao SW, Raki M, Gunnarsen KS, Loset GA, Lundin KE, Sandlie I, Sollid LM. Posttranslational modification of gluten shapes TCR usage in celiac disease. J Immunol 2011; 187:3064-71.
8. Giovannetti A, Pierdominici M, Di Iorio A, Cianci R, Murdaca G, Puppo F, Pandolfi F, Paganelli R. Apoptosis in the homeostasis of the immune system and in human immune mediated diseases. Curr Pharm Des 2008; 14:253-68. (Pubitemid 351516870)
9. Buri C, Burri P, Bahler P, Straumann A, Muller-Schenker B, Birrer S, Mueller C. Cytotoxic T cells are preferentially activated in the duodenal epithelium from patients with florid coeliac disease. J Pathol 2005; 206:178-85. (Pubitemid 40754021)
10. Pandolfi F, Corte G, Quinti I, Fiorilli M, Frieligsdorf A, Bargellesi A, Aiuti F. Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia. Clin Exp Immunol 1983; 51:470-4. (Pubitemid 13144120)
11. Hishii M, Kurnick JT, Ramirez-Montagut T, Pandolfi F. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. Clin Exp Immunol 1999; 116:388-94. (Pubitemid 29258085)
12. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500.
13. Pandolfi F, Cianci R, Pagliari D, Landolfi R, Cammarota G. Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm 2009; 2009:132028.
14. Frisullo G, Nociti V, Iorio R, et al. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum Immunol 2009; 70:430-5.
15. Brazowski E, Cohen S, Yaron A, Filip I, Eisenthal A. FOXP3 expression in duodenal mucosa in pediatric patients with celiac disease. Pathobiology 2010; 77:328-34.
16. Monteleone I, Sarra M, Del Vecchio Blanco G, et al. Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010; 184:2211-8.
17. Castellanos-Rubio A, Santin I, Irastorza I, Castano L, Carlos Vitoria J, Ramon Bilbao J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 2009; 42:69-73.
18. Fernandez S, Molina IJ, Romero P, et al. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol 2011; 106:528-38.
19. Zanzi D, Stefanile R, Santagata S, et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am J Gastroenterol 2011; 106:1308-17.
20. Simone R, Brizzolara R, Chiappori A, et al. A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury. Int Immunol 2009; 21:1037-45.
21. Hunt KA, McGovern DP, Kumar PJ, et al. A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet 2005; 13:440-4. (Pubitemid 40520935)
22. Haimila K, Einarsdottir E, de Kauwe A, et al. The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency. Genes Immun 2009; 10:151-61.
23. Hmida NB, Ahmed MB, Moussa A, et al. Impaired Control of Effector T Cells by Regulatory T Cells: A Clue to Loss of Oral Tolerance and Autoimmunity in Celiac Disease? Am J Gastroenterol 2011; doi: 10.1038/ajg.2011.397.
24. Peluso I, Fantini MC, Fina D, Caruso R, Boirivant M, MacDonald TT, Pallone F, Monteleone G. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007; 178:732-9. (Pubitemid 46095145)
25. Benahmed M, Meresse B, Arnulf B, et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007; 132:994-1008. (Pubitemid 46440858)
26. Barone MV, Zanzi D, Maglio M, et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One 2011; 6:e17039.
27. Bodd M, Raki M, Tollefsen S, Fallang LE, Bergseng E, Lundin KE, Sollid LM. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010; 3:594-601.
28. Cianci R, Pagliari D, Pietroni V, Landolfi R, Pandolfi F. Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. J Biol Regul Homeost Agents 2010; 24:239-49.
29. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30:646-55.
30. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4:7-25. (Pubitemid 8376317)
31. Park D, Sykes DB, Scadden DT. The hematopoietic stem cell niche. Front Biosci 2012; 17:30-9.
32. Scadden DT. The stem-cell niche as an entity of action. Nature 2006; 441:1075-9. (Pubitemid 43990719)
33. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140:957-65.
34. Wirtz S, Billmeier U, McHedlidze T, Blumberg RS, Neurath MF. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 2011; 141:1875-86.
35. O'Connor W, Jr., Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009; 10:603-9.
36. Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med 2011; 269:604-13.
37. Salvati VM, MacDonald TT, Bajaj-Elliott M, Borrelli M, Staiano A, Auricchio S, Troncone R, Monteleone G. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002; 50:186-90. (Pubitemid 34087929)
38. Gianfrani C, Levings MK, Sartirana C, et al. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol 2006; 177:4178-86. (Pubitemid 44359953)
39. Colgan J, Rothman P. All in the family: IL-27 suppression of T(H)-17 cells. Nat Immunol 2006; 7:899-901. (Pubitemid 44263899)
40. Jankowski M, Kopinski P, Goc A. Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp (Warsz) 2010; 58:417-25.
41. Batten M, Li J, Yi S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7:929-36. (Pubitemid 44263906)
42. Liu H, Rohowsky-Kochan C. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J Interferon Cytokine Res 2011; 31:459-69.
43. Olen O, Askling J, Ludvigsson JF, Hildebrand H, Ekbom A, Smedby KE. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011; 43:862-8.
44. Chandesris MO, Malamut G, Verkarre V, et al. Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives. Gastroenterol Clin Biol 2010; 34:590-605.
45. Di Sabatino A, Ciccocioppo R, Cupelli F, et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006; 55:469-77.
46. Sieniawski MK, Lennard AL. Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies. Curr Hematol Malig Rep 2011; 6:231-40.
47. Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011; 118:148-55.
48. Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Reunala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38:374-80. (Pubitemid 44356222)
49. Holtmeier W, Pfander M, Zollner TM, Kaufmann R, Caspary WF. Distinct TCR delta repertoires are present in the cutaneous lesions and inflamed duodenum of patients with dermatitis herpetiformis. Exp Dermatol 2002; 11:527-31. (Pubitemid 37009764)
50. Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010; 59:547-57.
51. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999; 94:260-4. (Pubitemid 29300157)